Tanvex BioPharma (Taiwan) Probability of Future Stock Price Finishing Over 41.05
| 6541 Stock | TWD 41.05 0.95 2.26% |
Tanvex |
Tanvex BioPharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Tanvex BioPharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Tanvex BioPharma can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Tanvex BioPharma generated a negative expected return over the last 90 days | |
| Tanvex BioPharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.41 M. Net Loss for the year was (1.54 B) with profit before overhead, payroll, taxes, and interest of 3.55 M. | |
| Tanvex BioPharma has accumulated about 1.65 B in cash with (1.39 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.29. | |
| Roughly 54.0% of the company shares are owned by insiders or employees |
Tanvex BioPharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Tanvex Stock often depends not only on the future outlook of the current and potential Tanvex BioPharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Tanvex BioPharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 352.5 M |
Tanvex BioPharma Technical Analysis
Tanvex BioPharma's future price can be derived by breaking down and analyzing its technical indicators over time. Tanvex Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Tanvex BioPharma. In general, you should focus on analyzing Tanvex Stock price patterns and their correlations with different microeconomic environments and drivers.
Tanvex BioPharma Predictive Forecast Models
Tanvex BioPharma's time-series forecasting models is one of many Tanvex BioPharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Tanvex BioPharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Tanvex BioPharma
Checking the ongoing alerts about Tanvex BioPharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Tanvex BioPharma help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Tanvex BioPharma generated a negative expected return over the last 90 days | |
| Tanvex BioPharma has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 5.41 M. Net Loss for the year was (1.54 B) with profit before overhead, payroll, taxes, and interest of 3.55 M. | |
| Tanvex BioPharma has accumulated about 1.65 B in cash with (1.39 B) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.29. | |
| Roughly 54.0% of the company shares are owned by insiders or employees |
Additional Tools for Tanvex Stock Analysis
When running Tanvex BioPharma's price analysis, check to measure Tanvex BioPharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tanvex BioPharma is operating at the current time. Most of Tanvex BioPharma's value examination focuses on studying past and present price action to predict the probability of Tanvex BioPharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tanvex BioPharma's price. Additionally, you may evaluate how the addition of Tanvex BioPharma to your portfolios can decrease your overall portfolio volatility.